Adjuvant Therapy for Diabetes Mellitus-2
Phase 2
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2024/02/063063
- Lead Sponsor
- Sharda University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Early diagnosed Type 2 diabetes
Age 30-40
Males
BMI 20-25
diet or tablet treatment for diabetes
Exclusion Criteria
Joint (Lower limb) pathologies
diseases other than type 2 diabetes (e.g. Cardiac issues, Hyperlipidemia, Metabolic disorders)
insulin treatment
Females
Age >40
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To uncover and understand the physiological and molecular mechanisms by which Tabata Training impacts individuals with Type-2 diabetesTimepoint: 1. at the starting of study <br/ ><br>2. after 6 months of intervention
- Secondary Outcome Measures
Name Time Method ILTimepoint: NA